E Fund Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.12M | Buy |
3,881
+591
| +18% | +$170K | 0.05% | 156 |
|
|
2025
Q1 | $1.01M | Buy |
3,290
+655
| +25% | +$202K | 0.05% | 168 |
|
|
2024
Q4 | $930K | Sell |
2,635
-569
| -18% | -$201K | 0.05% | 154 |
|
|
2024
Q3 | $1.15M | Sell |
3,204
-704
| -18% | -$252K | 0.06% | 132 |
|
|
2024
Q2 | $1.24M | Buy |
3,908
+2,125
| +119% | +$677K | 0.07% | 108 |
|
|
2024
Q1 | $410K | Sell |
1,783
-205
| -10% | -$47.1K | 0.03% | 210 |
|
|
2023
Q4 | $437K | Sell |
1,988
-44
| -2% | -$9.68K | 0.03% | 185 |
|
|
2023
Q3 | $459K | Buy |
2,032
+77
| +4% | +$17.4K | 0.03% | 135 |
|
|
2023
Q2 | $432K | Buy |
1,955
+266
| +16% | +$58.8K | 0.03% | 146 |
|
|
2023
Q1 | $378K | Buy |
1,689
+181
| +12% | +$40.5K | 0.03% | 185 |
|
|
2022
Q4 | $419K | Sell |
1,508
-623
| -29% | -$173K | 0.03% | 173 |
|
|
2022
Q3 | $446K | Buy |
2,131
+146
| +7% | +$30.6K | 0.04% | 148 |
|
|
2022
Q2 | $468K | Buy |
1,985
+434
| +28% | +$102K | 0.04% | 156 |
|
|
2022
Q1 | $278K | Buy |
+1,551
| New | +$278K | 0.01% | 226 |
|